Monarch Partners Asset Management LLC Mannkind Corp Transaction History

Monarch Partners Asset Management LLC

  • $328 Million
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022
SELL
$2.67 - $4.77 $1.12 Million - $2.01 Million
-420,478 Closed
0 $0
Q4 2021

Feb 03, 2022
BUY
$4.05 - $5.37 $144,119 - $191,091
35,585 Added 9.25%
420,478 $1.84 Million
Q3 2021

Nov 04, 2021
BUY
$3.89 - $5.48 $1.5 Million - $2.11 Million
384,893 New
384,893 $1.67 Million

Others Institutions Holding MNKD

# of Institutions
245
Shares Held
148M
Call Options Held
1.62M
Put Options Held
802K
View Full List

About MANNKIND CORP

MNKD Quotes by TradingView
  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Monarch Partners Asset Management LLC Portfolio

Follow Monarch Partners Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Partners Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Partners Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email